This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: The National Institutes of Pharmaceutical R&d Co., Ltd.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Libin Zong: Innovator in Pyrrolo-Aromatic Heterocyclic Compounds
Introduction
Libin Zong is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of pyrrolo-aromatic heterocyclic compounds. His work focuses on the preparation methods and medical applications of these compounds, which have potential therapeutic uses.
Latest Patents
Libin Zong holds a patent for a pyrrolo-aromatic heterocyclic compound, along with its preparation method and medical use. This invention relates to a compound represented by a specific formula, which serves as a BTK kinase inhibitor. The pharmaceutical composition derived from this compound can be utilized in treating diseases associated with BTK kinase activity, including inflammations, autoimmune disorders, and cancers. The detailed definition of each substituent in the formula is provided in the patent description.
Career Highlights
Throughout his career, Libin Zong has worked with prominent organizations, including the National Institutes of Pharmaceutical Research and Development. His expertise in pharmaceutical research has led to advancements in the understanding and treatment of various medical conditions.
Collaborations
Libin Zong has collaborated with notable colleagues such as Huijun Yin and Xu Yan. Their combined efforts in research have contributed to the development of innovative pharmaceutical solutions.
Conclusion
Libin Zong's work in the field of pyrrolo-aromatic heterocyclic compounds showcases his dedication to advancing medical science. His patent and collaborations highlight the importance of innovation in addressing complex health challenges.